These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12768499)

  • 1. The low nanomolar levels of N G-monomethylarginine in serum and urine of patients with chronic renal insufficiency are not significantly different from control levels.
    Torremans A; Marescau B; Vanholder R; De Smet R; Billiouw JM; De Deyn PP
    Amino Acids; 2003 Jun; 24(4):375-81. PubMed ID: 12768499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accumulation of vitamin E metabolites in the blood of renal failure patients.
    Galli F; Floridi AG; Floridi A; Buoncristiani U
    Clin Nutr; 2004 Apr; 23(2):205-12. PubMed ID: 15030960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum levels and urinary excretion of methylguanidine in chronic renal failure.
    Stein IM; Perez G; Johnson R; Cummings NB
    J Lab Clin Med; 1971 Jun; 77(6):1020-4. PubMed ID: 5559857
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of renal failure on blood levels of cimetidine.
    Ma KW; Brown DC; Masler DS; Silvis SE
    Gastroenterology; 1978 Feb; 74(2 Pt 2):473-7. PubMed ID: 620915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxalic Acid as a uremic toxin.
    Mydlík M; Derzsiová K
    J Ren Nutr; 2008 Jan; 18(1):33-9. PubMed ID: 18089441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum paraoxonase activity in uremic predialysis and hemodialysis patients.
    Dirican M; Akca R; Sarandol E; Dilek K
    J Nephrol; 2004; 17(6):813-8. PubMed ID: 15593056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac troponin I in patients with chronic kidney disease treated conservatively or undergoing long-term haemodialysis.
    Flisiński M; Strózecki P; Stefańska A; Zarzycka-Lindner G; Brymora A; Manitius J
    Kardiol Pol; 2007 Sep; 65(9):1068-75; discussion 1076-8. PubMed ID: 17975754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased indoleamine 2,3-dioxygenase (IDO) activity and elevated serum levels of tryptophan catabolites in patients with chronic kidney disease: a possible link between chronic inflammation and uraemic symptoms.
    Schefold JC; Zeden JP; Fotopoulou C; von Haehling S; Pschowski R; Hasper D; Volk HD; Schuett C; Reinke P
    Nephrol Dial Transplant; 2009 Jun; 24(6):1901-8. PubMed ID: 19155537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Guanidino compounds in serum and urine of nondialyzed patients with chronic renal insufficiency.
    Marescau B; Nagels G; Possemiers I; De Broe ME; Becaus I; Billiouw JM; Lornoy W; De Deyn PP
    Metabolism; 1997 Sep; 46(9):1024-31. PubMed ID: 9284891
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Infusion of radiocontrast agents induces exaggerated release of urinary endothelin in patients with impaired renal function.
    Fujisaki K; Kubo M; Masuda K; Tokumoto M; Hirakawa M; Ikeda H; Matsui R; Matsuo D; Fukuda K; Kanai H; Hirakata H; Iida M
    Clin Exp Nephrol; 2003 Dec; 7(4):279-83. PubMed ID: 14712357
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Age-related differences in renal function at onset of renal replacement therapy in chronic kidney disease stage 5 patients.
    Balogun SA; Balogun RA; Evans J
    QJM; 2006 Sep; 99(9):595-9. PubMed ID: 16905750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth hormone, IGF-I and its binding proteins (IGFBP-1 and -3) in adult uraemic patients undergoing peritoneal dialysis and haemodialysis.
    Iglesias P; Díez JJ; Fernández-Reyes MJ; Méndez J; Bajo MA; Aguilera A; Selgas R
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):741-9. PubMed ID: 15163339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary excretion of amylase in patients with renal insufficiency. Correlation with blood amylase, urine creatinine and proteinuria levels].
    García-Valdecasas Valverde J; González Calvín J; Hervás Sánchez J; Manjón García M; Delgado Lillo R; Cerezo Morales S; Peña Yáñez A
    Rev Esp Enferm Apar Dig; 1984 Jun; 65(6):491-7. PubMed ID: 6206529
    [No Abstract]   [Full Text] [Related]  

  • 15. Renal effects of N-acetylcysteine in patients at risk for contrast nephropathy: decrease in oxidant stress-mediated renal tubular injury.
    Drager LF; Andrade L; Barros de Toledo JF; Laurindo FR; Machado César LA; Seguro AC
    Nephrol Dial Transplant; 2004 Jul; 19(7):1803-7. PubMed ID: 15128882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free and total plasma malondialdehyde in chronic renal insufficiency and in dialysis patients.
    De Vecchi AF; Bamonti F; Novembrino C; Ippolito S; Guerra L; Lonati S; Salini S; Aman CS; Scurati-Manzoni E; Cighetti G
    Nephrol Dial Transplant; 2009 Aug; 24(8):2524-9. PubMed ID: 19264746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of chronic renal failure on the pharmacokinetics of lidocaine in patients receiving and not receiving hemodialysis.
    De Martin S; Orlando R; Bertoli M; Pegoraro P; Palatini P
    Clin Pharmacol Ther; 2006 Dec; 80(6):597-606. PubMed ID: 17178261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of creatol, an in vivo biomarker of hydroxyl radical, in patients with chronic renal failure.
    Ienaga K; Nakamura K; Fujisawa T; Fukunaga Y; Nihei H; Narita M; Tomino Y; Sanaka T; Aoyagi K; Nakano K; Koide H
    Ren Fail; 2007; 29(3):279-83. PubMed ID: 17497440
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal function and serum albumin at the start of dialysis in 514 Chinese ESRD in-patients.
    Liu H; Peng Y; Liu F; Xiao H; Chen X; Huang A; Liu Y
    Ren Fail; 2008; 30(7):685-90. PubMed ID: 18704816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemodialysis procedure does not affect the levels of sICAM-1 and sVCAM-1 in patients with end stage renal disease.
    Liakopoulos V; Eleftheriadis T; Kyropoulos T; Voliotis G; Potamianos S; Zengos N; Stefanidis I; Heintz B
    Ren Fail; 2005; 27(3):315-21. PubMed ID: 15957549
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.